eJHaem (Aug 2023)

Cerebral localization of chronic myelomonocytic leukemia and improvement with high‐dose cytarabine: A case report

  • Clémence Haméon,
  • Antoine Machet,
  • Laurianne Drieu La Rochelle,
  • Nicolas Vallet,
  • Julien Lejeune,
  • Noémie Ravalet,
  • Jean‐Philippe Cottier,
  • Olivier Hérault,
  • Emmanuel Gyan

DOI
https://doi.org/10.1002/jha2.740
Journal volume & issue
Vol. 4, no. 3
pp. 844 – 847

Abstract

Read online

Abstract Chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm characterized by the infiltration of blood and bone marrow by immature monocytes, in which extra‐hematopoietic localization is uncommon. We report the case of a 69‐year‐old‐man with highly likely ectopic brain CMML involvement by MRI. Without the possibility of cerebral biopsy and with a negative infectious disease assessment, high‐dose cytarabine‐based chemotherapy was successfully administered. The favorable evolution in this case highlights the potential benefit of such treatment, even without a cerebral biopsy to confirm the disease. This case can aid clinical decision‐making in the future.

Keywords